Search results
Takeda pays $300M to license Protagonist drug for blood disorder
BioPharma Dive via Yahoo Finance· 3 months agoDive Brief: Protagonist Therapeutics, a biotechnology company focused on peptide drugs, is teaming...
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Benzinga via Yahoo Finance· 2 years agoPuma Biotechnology Inc (NASDAQ: PBYI) announced an agreement with Takeda Pharmaceutical Co Ltd...
Takeda, Nintendo among Japanese firms quietly celebrating weak yen
Reuters via Yahoo Finance· 2 years agoJapan's yen is at its weakest in decades and inflicting high costs of imported food and fuel on...
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib
Zacks via Yahoo Finance· 2 years agoPuma Biotechnology (PBYI) inks license agreement with Japan's Takeda Pharmaceuticals, gaining...
Exelixis' (EXEL) Prostate Cancer Study Meets Primary Endpoint
Zacks via Yahoo Finance· 8 months agoExelixis, Inc. EXEL and partner Ipsen announced that the late-stage CONTACT-02 study achieved one of...
Denali (DNLI) Q1 Earnings Miss Estimates, Pipeline in Focus
Zacks via Yahoo Finance· 12 months agoDenali Therapeutics DNLI incurred a loss of 80 cents per share for first-quarter 2023, wider than...
Top 20 Most Profitable Pharmaceutical Companies In The World
Insider Monkey via Yahoo Finance· 10 months agoIn this article, we will be covering the top 20 most profitable pharmaceutical companies in the...
Slumping China-bound Japanese exports raise fears of global downturn
Reuters via Yahoo News· 1 year agoJapan's export growth slowed sharply in December as China-bound shipments fell for the first time in...
Q2 2023 Model N Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 11 months agoParticipants Jason Blessing; President, CEO & Director; Model N, Inc. John Ederer; CFO; Model N, Inc. Craig Matthew Hettenbach; VP; Morgan Stanley, Research Division Dominique Calampiano Manansala ...
Lantheus Holdings Is Charting a Path to Sustainable Growth and Value
GuruFocus.com via Yahoo Finance· 4 months agoLantheus Holdings Inc. (NASDAQ:LNTH) is one of the leading companies in the global medical imaging...
